Product
111In-hu3S193
1 clinical trial
1 indication
Indication
Ovarian CancerClinical trial
Single-Dose, Cohort Study of Increasing Doses of Yttrium-90 Conjugated to Humanized Monoclonal Antibody 3S193 (90Y-hu3S193) in Patients With Advanced Ovarian CancerStatus: Completed, Estimated PCD: 2005-05-01